The Eshelman Institute seeks to fund translational research across UNC-Chapel Hill related to therapeutics focused on oncology, infectious diseases, and neuroscience, including rare diseases.
The Eshelman Institute for Innovation is pleased to announce that we are now accepting pre-proposals for our 2023 annual therapeutic grant cycle. Please note, that all faculty and staff at UNC-Chapel Hill are eligible to apply. All applicants are required to submit a pre-proposal as the first step in the application process (due Jan. 5, 2023).
The Eshelman Institute seeks to fund translational research related to therapeutics focused on oncology, infectious disease, and neuroscience (including rare diseases). However, the Institute welcomes ideas for devices and diagnostics, and other therapeutic areas and services.
The Eshelman Institute offers grants within three categories:
- Therapeutic – A project whose ultimate goal is to develop a drug
- Technology Platform – A project developing novel tool(s) with the potential to accelerate drug discovery/development)
- Other (e.g., devices, diagnostics, delivery)
To learn more about our grant process, please view our grant guidelines on our website.
If you have any questions or would like to meet with us to learn more, please email firstname.lastname@example.org